These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35488475)

  • 1. How longitudinal observational studies can guide screening strategy for rare diseases.
    Mütze U; Mengler K; Boy N; Gleich F; Opladen T; Garbade SF; Kölker S
    J Inherit Metab Dis; 2022 Sep; 45(5):889-901. PubMed ID: 35488475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry in clinical chemistry: the case of newborn screening.
    la Marca G
    J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modern face of newborn screening.
    Chien YH; Hwu WL
    Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S22-S29. PubMed ID: 36481189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
    Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
    Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology.
    Yu M; Xu J; Song X; Du J
    BMC Health Serv Res; 2022 Aug; 22(1):1039. PubMed ID: 35971172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
    Zhao Z; Chen C; Sun X; Zhou D; Huang X; Dong H
    J Med Screen; 2022 Mar; 29(1):12-20. PubMed ID: 34102920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
    Osara Y; Coakley K; Devarajan A; Singh RH
    Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into National Laboratory Newborn Screening and Future Prospects.
    Mujamammi AH
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
    Ozben T
    Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.
    Frazier DM; Millington DS; McCandless SE; Koeberl DD; Weavil SD; Chaing SH; Muenzer J
    J Inherit Metab Dis; 2006 Feb; 29(1):76-85. PubMed ID: 16601872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foundation of the Newborn Screening Translational Research Network and its tools for research.
    Lloyd-Puryear M; Brower A; Berry SA; Brosco JP; Bowdish B; Watson MS
    Genet Med; 2019 Jun; 21(6):1271-1279. PubMed ID: 30393376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America.
    Giugliani R
    J Inherit Metab Dis; 2012 Sep; 35(5):871-7. PubMed ID: 22231381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics professionals' opinions of whole-genome sequencing in the newborn period.
    Ulm E; Feero WG; Dineen R; Charrow J; Wicklund C
    J Genet Couns; 2015 Jun; 24(3):452-63. PubMed ID: 25348082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.
    De Jesús VR; Adam BW; Mandel D; Cuthbert CD; Matern D
    Mol Genet Metab; 2014; 113(1-2):67-75. PubMed ID: 25066104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening of mucopolysaccharidosis type I.
    Burlina AB; Gragnaniello V
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):257-277. PubMed ID: 35037566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.